文献速递免疫规划妇幼与学校卫生卫生政策与健康促进

发展中国家孕妇百日咳免疫规划的效果评估

Impact of a maternal immunization program against pertussis in a developing country.
PubMed 文献 · Vaccine · 2016-11-12

阿根廷2011年百日咳发病与死亡达高峰,超半数死亡婴儿小于2月龄无法接种疫苗;2012年起为所有妊娠20周后孕妇接种含Tdap疫苗。基于国家健康监测系统数据,以低覆盖率州为对照,用贝叶斯结构时间序列模型比较。高覆盖率州百日咳病例相对下降51%(95%CI -67%至-35%;p=0.001),2至6月龄婴儿发病下降44%(95%CI -66%至-24%;p=0.001);死亡数由2011年76例(2.9/10万)降至2013年10例(0.9/10万),下降87%。

要点

  • 高Tdap覆盖率州百日咳病例相对下降51%(95%CI -67%至-35%;p=0.001)。
  • 2至6月龄婴儿发病下降44%(95%CI -66%至-24%;p=0.001)。
  • 死亡数由2011年76例(2.9/10万)降至2013年10例(0.9/10万),下降87%。

核心结论

  • 在发展中国家,孕妇接种Tdap对6月龄以下婴儿显示年龄依赖性保护效果。

研究设计与样本

  • 基于阿根廷健康监测系统数据,将各州按Tdap疫苗覆盖率分为高(>50)与低(⩽50)两组,以低覆盖区为对照,用贝叶斯结构时间序列模型比较Tdap项目实施前后的时间序列。

主要发现

  • 高覆盖州与低覆盖区相比,百日咳病例相对下降51%(95%CI -67%至-35%;p=0.001)。
  • 2至6月龄婴儿发病相对下降44%(95%CI -66%至-24%;p=0.001)。
  • 死亡数2011年最高为76例,发病率为2.9/10万;与2011年相比,2013年降至10例(0.9/10万),下降87%。

关键数值与推荐

  • 孕妇在妊娠20周后接种含Tdap疫苗。
  • 高覆盖率定义为Tdap疫苗覆盖率>50,低覆盖率定义为⩽50。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pertussis disease is a growing concern for developing countries. In Argentina, rates of illness and death peaked in 2011. More than 50% of fatalities due to pertussis occurred in infants younger than two months of age, too young for vaccination. In 2012, the government offered immunization with a vaccine containing Tdap to all pregnant women after 20weeks of gestation with the intent of reducing morbidity and mortality in young infants. METHODS: Maternal acellular pertussis vaccine impact on reducing infant disease burden was estimated based on data from the Argentinean Health Surveillance System. We divided Argentinean states in two groups experiencing high (>50) and low (⩽50) Tdap vaccine coverage and compared these two groups using a Bayesian structural time-series model. Low coverage regions were used as a control group, and the time series were compared before and after the implementation of the Tdap program. FINDINGS: We observed a relative reduction of 51% (95% CI [-67%, -35%]; p=0.001) in pertussis cases in high coverage states in comparison with the low coverage areas. Analysis of infants between two and six months showed a 44% (95% CI [-66%, -24%]; p=0.001) reduction in illness. Number of deaths was highest in 2011 with 76 fatalities, for an incidence rate of 2.9 per 100,000. Comparing with 2011, rates decreased by 87% to 10 subjects, or 0.9 per 100,000 in 2013. INTERPRETATION: We show an age-dependent protective effect of maternal Tdap immunization in a developing country for infants younger than six months.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Vizzotti C, Juarez MV, Bergel E, et al. Impact of a maternal immunization program against pertussis in a developing country. Vaccine. 2016. PMID: 27847175. doi:10.1016/j.vaccine.2016.10.081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。